ArticleJournal of thoracic disease2025

Comparison of neoadjuvant chemotherapy plus immunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma patients: efficacy and safety outcomes.

Shuming Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.